August 14, 2026 10:05 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe | From guns to glamour: Former women Maoists walk the ramp in Chhattisgarh | Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute | Netaji row explodes in Bengal: Suvendu Adhikari orders police action over ‘derogatory’ posts | Kolkata's NRS Hospital nurse found dead in washroom during night shift
Omicron
Pixabay

Russian nasal vaccine effective against Omicron variant: Researchers

| @indiablooms | Mar 20, 2022, at 08:31 pm

Moscow/UNI/Sputnik: The new Russian nasal vaccine against the coronavirus infection has demonstrated effectiveness against the Omicron variant, Alexander Gintsburg, the director of Russia's Gamaleya Research Center for Epidemiology and Microbiology, told Sputnik.

"Yes, it is being tested against Omicron, it works," Gintsburg said. According to the chief researcher, the new vaccine will be used as a booster, in addition to the Sputnik V shots, for now, until there is enough evidence that this new intranasal vaccine gives the same level of protection as injection.

The Russian health ministry authorized clinical trials of the new intranasal vaccine in October 2021.

In November, Russian President Vladimir Putin offered to become a volunteer in the testing of the new vaccine and said that he felt no side effects after getting the procedure.

Gintsburg told Sputnik earlier this month that the new intranasal vaccine had already been administered to over 100 people, as part of the trials, who showed no negative side effects.

On Friday, the Gamaleya center applied for the registration of the new nasal vaccine against Covid-19. According to Gintsburg, it is expected to be registered earlier than planned.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.